Overview
F1 Pharma provides research and development services for the pharmaceutical industry. The company works in pharmaceutical technology, analytics, stability testing, and quality assurance. It also carries out comprehensive development of medicinal products, including new drug forms.
Financials
Revenue history (in k)
Data and insights are generated automatically based on financial statements and may contain errors. This analysis is for informational purposes only and does not constitute an official assessment of the company's credibility or business advice.
Statistics
How the company ranks by revenue within its industry, region and across Poland in 2025.
Results vs industry
News
Industry
Bank accounts
Registered as a VAT taxpayer on 2010-11-17. Active
69 2490 0005 0000 4520 2263 1981- 63 2490 0005 0000 4600 8881 8506
- 31 2490 0005 0000 4600 5036 7118
Debt
No entries in the National Debtors Register (KRZ). No proceedings in KRZ
MSiG notices
| Publication date | Event | |
|---|---|---|
| Apr 4, 2024 | Shareholders' meeting convened | |
| Dec 11, 2020 | Commercial Companies Code notice | |
| Nov 26, 2020 | Commercial Companies Code notice | |
| Oct 26, 2020 | Commercial Companies Code notice | |
| Oct 9, 2020 | Commercial Companies Code notice |
Public aid
9 public aid cases recorded, with a total value of $1,035,930.
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| Jun 3, 2020 | Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts | $79,573$79,573 | Polski Fundusz Rozwoju S.A. | |
| Aug 22, 2018 | Aid for research and development projects: industrial research | $488.6K$488,627 | Marszałek Województwa Małopolskiego | |
| Aug 22, 2018 | De minimis aid (in accordance with Commission Regulation No 1407/2013 or earlier) | $93,524$93,524 | Marszałek Województwa Małopolskiego |
Tenders
No recorded participation in tenders.
Regulatory authorisations
| Authority | Type | Status | |
|---|---|---|---|
 BDO | BDO register entry | Active |
Authorized Representatives
Manner of representation
The company is represented by two members of the management board acting jointly.
Supervisory board
Beneficial owners
| Person | Rights | |
|---|---|---|
Mirosław Marek Strózik (63)  | Shareholder of a joint-stock company, 54.0% |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| PoltregS.A. | $1,906,011.66 | poltreg.com | ||
| Labor Przedsiębiorstwo Farmaceutyczno - Chemicznesp. z o.o. | $1,184,204.34 | labor.com.pl | ||
| Pexon Polandsp. z o.o. | $122,615.96 | pexon.pl | ||
| LideoS.A. | $95,067.91 | lideo.tech | ||
| Ampliconsp. z o.o. | $48,330.99 | amplicon.pl |
FAQ
Last updated: 2026-07-28